Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) institutional holders · P/E 42, rev $3.02B
Amneal Pharmaceuticals, Inc. Class A Common Stock 13F cache, top 2 holders by reported value. Each row is the filer's newest cached 13F for quarters ended 2026-06-30 or later, share lines summed, options excluded; value is the 13F-reported market value in US dollars. Filers whose newest cached 13F is older are omitted.
| Holder | Shares | Value | Report |
|---|---|---|---|
| STATE STREET CORP | 7,356,977 | $127.3M | 2026-06-30 |
| FMR LLC | 825,120 | $14.3M | 2026-06-30 |
AMRX institutional holders FAQ
How many AMRX 13F holders are listed on this page?
This page lists 2 cached Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) 13F holders. Holders: https://lician.com/institutional/amrx
Who is the largest AMRX 13F holder by reported value?
The largest cached 13F holder by reported value on this page is STATE STREET CORP. Filer: https://lician.com/institutional/amrx/93751. Holders: https://lician.com/institutional/amrx
What value and shares did the largest AMRX 13F holder report?
STATE STREET CORP, the largest cached 13F holder by reported value on this page, reported 7,356,977 shares and a value of $127.3M.
What is the latest AMRX 13F report date on this page?
The latest cached 13F report date on this Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) holders table is Jun 30, 2026.
Which AMRX 13F holders report the largest positions?
The largest cached 13F holders by reported value on this Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) page are STATE STREET CORP and FMR LLC. Holders: https://lician.com/institutional/amrx
Where are AMRX institutional holders listed?
Cached 13F holders for Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) are listed at https://lician.com/institutional/amrx. Filer directory: https://lician.com/holders
What is AMRX's P/E ratio?
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) trailing P/E is 42.5 on the latest cached fundamentals snapshot.
What is AMRX's latest revenue?
Latest cached Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) revenue for Dec 31, 2025 was $3.02B. Statements: https://lician.com/financials/amrx
Not investment advice. Cached rows, not a live tape.